Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

First patient enrolled in phase II study of subcutaneous MABp1 in hidradenitis suppurativa

July 11, 2018

miRagen launches phase II study of MRG-201

July 11, 2018

Cassiopea reports phase III topline results for topical antiandrogen Winlevi for acne

July 10, 2018

Leo Pharma presents phosphodiesterase PDE4 inhibitors

July 9, 2018

Phase IIb study of LL-37 receives approval in Sweden

July 6, 2018

CYP11B1 enzyme, a potential predictive biomarker for healing failure in diabetic foot ulcers

July 6, 2018

Sanofi and Lead Pharma Holding patent RORC modulators

July 5, 2018

Aslan Pharmaceuticals submits clinical trial authorization

July 4, 2018

LEO Pharma initiates phase I study of LEO-138559

July 2, 2018

Japan Tobacco and Torii Pharmaceutical discontinue development of JTS-661

June 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....